• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bladder cancer: Multi-omic profiling refines the molecular view.

作者信息

Hurst Carolyn D, Knowles Margaret A

机构信息

Leeds Institute of Cancer and Pathology, St James's University Hospital, Beckett Street, University of Leeds, Leeds LS9 7TF, UK.

出版信息

Nat Rev Clin Oncol. 2018 Apr;15(4):203-204. doi: 10.1038/nrclinonc.2017.195. Epub 2017 Dec 19.

DOI:10.1038/nrclinonc.2017.195
PMID:29255240
Abstract
摘要

相似文献

1
Bladder cancer: Multi-omic profiling refines the molecular view.膀胱癌：多组学分析完善分子视角。
Nat Rev Clin Oncol. 2018 Apr;15(4):203-204. doi: 10.1038/nrclinonc.2017.195. Epub 2017 Dec 19.
2
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.对非肌肉浸润性膀胱癌进行分层分子谱分析可增强生物学、临床和治疗方面的认识。
Cell Rep Med. 2021 Dec 21;2(12):100472. doi: 10.1016/j.xcrm.2021.100472.
3
Molecular profiling in muscle-invasive bladder cancer: more than the sum of its parts.肌层浸润性膀胱癌的分子谱分析：整体大于部分之和。
J Pathol. 2019 Apr;247(5):563-573. doi: 10.1002/path.5230. Epub 2019 Feb 20.
4
Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.通过全基因组基因表达谱分析鉴定人类膀胱癌中差异表达的基因。
Oncol Rep. 2006 Sep;16(3):521-31.
5
Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors.E2F1 及其相关基因的表达特征可预测膀胱癌从浅表到浸润的进展。
J Clin Oncol. 2010 Jun 1;28(16):2660-7. doi: 10.1200/JCO.2009.25.0977. Epub 2010 Apr 26.
6
Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy.上调的SMYD3通过靶向BCLAF1并激活自噬促进膀胱癌进展。
Tumour Biol. 2016 Jun;37(6):7371-81. doi: 10.1007/s13277-015-4410-2. Epub 2015 Dec 16.
7
Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.膀胱进行性乳头状非浸润性癌的基因表达谱分析。
Clin Cancer Res. 2005 Jun 15;11(12):4415-29. doi: 10.1158/1078-0432.CCR-05-0259.
8
Novel protein signatures suggest progression to muscular invasiveness in bladder cancer.新型蛋白质标志物提示膀胱癌向肌层浸润进展。
PLoS One. 2018 Nov 12;13(11):e0206475. doi: 10.1371/journal.pone.0206475. eCollection 2018.
9
Prognosis stratification and personalized treatment in bladder cancer through a robust immune gene pair-based signature.通过基于强大免疫基因对的特征实现膀胱癌的预后分层和个性化治疗。
Clin Transl Med. 2021 Jun;11(6):e453. doi: 10.1002/ctm2.453.
10
New insights into subtypes of invasive bladder cancer: considerations of the clinician.浸润性膀胱癌亚型的新见解：临床医生的考量
Eur Urol. 2014 Oct;66(4):609-10. doi: 10.1016/j.eururo.2014.05.006. Epub 2014 May 27.

引用本文的文献

1
Molecular classification of urothelial bladder carcinoma.尿路上皮膀胱癌的分子分类。
Mol Biol Rep. 2023 Sep;50(9):7867-7877. doi: 10.1007/s11033-023-08689-7. Epub 2023 Jul 31.
2
Allosteric activation of the metabolic enzyme GPD1 inhibits bladder cancer growth via the lysoPC-PAFR-TRPV2 axis.变构激活代谢酶 GPD1 通过溶脂磷脂酸-PAFR-TRPV2 轴抑制膀胱癌生长。
J Hematol Oncol. 2022 Jul 14;15(1):93. doi: 10.1186/s13045-022-01312-5.
3
Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system.

本文引用的文献

1
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.肌层浸润性膀胱癌的综合分子特征分析
Cell. 2017 Oct 19;171(3):540-556.e25. doi: 10.1016/j.cell.2017.09.007. Epub 2017 Oct 5.
2
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.肌层浸润性膀胱癌分子亚型对新辅助化疗后反应和生存预测的影响。
Eur Urol. 2017 Oct;72(4):544-554. doi: 10.1016/j.eururo.2017.03.030. Epub 2017 Apr 5.
3
Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification.
长链非编码 RNA 预测膀胱癌术后复发并建立新的分子分类系统。
Cancer Med. 2022 Jan;11(2):539-552. doi: 10.1002/cam4.4443. Epub 2021 Nov 24.
4
Characteristics of upper urinary tract urothelial carcinoma in the context of bladder cancer: a narrative review.膀胱癌背景下上尿路尿路上皮癌的特征：一项叙述性综述。
Transl Androl Urol. 2021 Oct;10(10):4036-4050. doi: 10.21037/tau-20-1472.
5
The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer.FGFR3表达在T1期非肌层浸润性膀胱癌患者中的预后价值
Cancer Manag Res. 2021 Aug 20;13:6567-6578. doi: 10.2147/CMAR.S318893. eCollection 2021.
6
Prognostic Role of Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma.原发性管腔型非肌层浸润性膀胱癌中表达状态及肿瘤相关微小RNA水平与PD-L1表达的相关性及其预后作用
Life (Basel). 2020 Nov 23;10(11):305. doi: 10.3390/life10110305.
7
Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers.细胞角蛋白 19 片段 21.1、ERCC1、p53、FGFR3 和 TATI 作为生物标志物在膀胱癌中的诊断和预后潜能。
Int J Mol Sci. 2020 May 9;21(9):3360. doi: 10.3390/ijms21093360.
8
Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.以竞争葡萄糖代谢为靶点增强膀胱癌免疫治疗。
Nat Rev Urol. 2020 Feb;17(2):77-106. doi: 10.1038/s41585-019-0263-6. Epub 2020 Jan 17.
9
MicroRNAs Which Can Prognosticate Aggressiveness of Bladder Cancer.可预测膀胱癌侵袭性的微小RNA
Cancers (Basel). 2019 Oct 14;11(10):1551. doi: 10.3390/cancers11101551.
10
DNA topoisomerase IIα and RAD21 cohesin complex component are predicted as potential therapeutic targets in bladder cancer.DNA拓扑异构酶IIα和RAD21黏连蛋白复合体成分被预测为膀胱癌潜在的治疗靶点。
Oncol Lett. 2019 Jul;18(1):518-528. doi: 10.3892/ol.2019.10365. Epub 2019 May 17.
尿路上皮癌的分子分类：整体mRNA分类与肿瘤细胞表型分类
J Pathol. 2017 May;242(1):113-125. doi: 10.1002/path.4886. Epub 2017 Mar 28.
4
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.阿替利珠单抗用于接受铂类化疗后病情进展的局部晚期和转移性尿路上皮癌患者：一项单臂、多中心、2期试验。
Lancet. 2016 May 7;387(10031):1909-20. doi: 10.1016/S0140-6736(16)00561-4. Epub 2016 Mar 4.
5
Global cancer statistics, 2012.全球癌症统计数据，2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
6
Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.鉴定具有不同一线化疗敏感性的浸润性膀胱癌的基底和腔面亚型。
Cancer Cell. 2014 Feb 10;25(2):152-65. doi: 10.1016/j.ccr.2014.01.009.
7
Comprehensive molecular characterization of urothelial bladder carcinoma.尿路上皮膀胱癌的综合分子特征分析
Nature. 2014 Mar 20;507(7492):315-22. doi: 10.1038/nature12965. Epub 2014 Jan 29.
8
Discovery and saturation analysis of cancer genes across 21 tumour types.在 21 种肿瘤类型中发现和饱和分析癌症基因。
Nature. 2014 Jan 23;505(7484):495-501. doi: 10.1038/nature12912. Epub 2014 Jan 5.
9
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.APOBEC 胞嘧啶脱氨酶致突变模式广泛存在于人类癌症中。
Nat Genet. 2013 Sep;45(9):970-6. doi: 10.1038/ng.2702. Epub 2013 Jul 14.
10
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis.美国特定分期膀胱癌的发病率、生存率和死亡率：趋势分析。
Cancer Epidemiol. 2013 Jun;37(3):219-25. doi: 10.1016/j.canep.2013.02.002. Epub 2013 Feb 26.